Post-approval studies (Phase 4)UnknownNCT02621541What this trial is testingNonfunctional Pancreatic NET and PET ImagingWho this might be right forDiagnosis Turku University Hospital 20
Not applicableLooking for participantsNCT07273409What this trial is testingPancreatic Neuroendocrine Tumour - Optimal Surgical Debulking or NotWho this might be right forPancreatic Neuroendocrine Tumor Uppsala University 200
Not applicableActive Not RecruitingNCT06406387What this trial is testingATRX/DAXX in EUS-FNB Specimens of Pan-NETsWho this might be right forPancreatic Neuroendocrine Tumor Azienda Ospedaliera Universitaria Integrata Verona 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT04140526What this trial is testingSafety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLCWho this might be right forNon Small Cell Lung CancerAdvanced Solid TumorMetastatic Melanoma+16 more OncoC4, Inc. 733
Testing effectiveness (Phase 2)UnknownNCT05199584What this trial is testingA Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function MutationsWho this might be right forSolid Tumors With PTCH1 Loss-of-function Mutations Endeavor Biomedicines, Inc. 44
Large-scale testing (Phase 3)Active Not RecruitingNCT04919226What this trial is testingLutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) - COMPOSEWho this might be right forNeuroendocrine Tumors ITM Solucin GmbH 259
Not applicableLooking for participantsNCT07403630What this trial is testingINTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP)Who this might be right forAcute LeukemiaMultiple MyelomaChronic Myeloproliferative Neoplasm+7 more Azienda Ospedaliero-Universitaria di Parma 300
Not applicableStudy completedNCT03834701What this trial is testingEndoscopic Ultrasound-guided RadioFrequency Ablation for the Treatment Pancreatic NeuroEndocrine NeoplasmsWho this might be right forNeuroendocrine TumorsNeuroendocrine CarcinomaPancreas Neoplasm+1 more Catholic University of the Sacred Heart 60
Large-scale testing (Phase 3)Active Not RecruitingNCT03375320What this trial is testingTesting Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid TumorsWho this might be right forFunctioning Pancreatic Neuroendocrine TumorIntermediate Grade Lung Neuroendocrine NeoplasmLocally Advanced Digestive System Neuroendocrine Neoplasm+25 more National Cancer Institute (NCI) 298
Not applicableUnknownNCT03084770What this trial is testingAsymptomatic Small Pancreatic Endocrine Neoplasms.Who this might be right forNon Functioning Pancreatic Endocrine Tumor IRCCS San Raffaele 1,000
Not applicableStudy completedNCT03817866What this trial is testingChromogranin A as Blood Marker in Cancer PatientsWho this might be right forGastric NeoplasmsPancreatic NeoplasmsSmall Intestinal Neoplasms+1 more Brahms AG 175
Large-scale testing (Phase 3)Study completedNCT00842348What this trial is testingStudy of Lanreotide Autogel 120 mg in Patients With Non-functioning Entero- Pancreatic Endocrine TumourWho this might be right forNon Functioning Entero-pancreatic Endocrine Tumour Ipsen 89
Testing effectiveness (Phase 2)Study completedNCT02955069What this trial is testingStudy of Efficacy and Safety of PDR001 in Patients With Advanced or Metastatic, Well-differentiated, Non-functional Neuroendocrine Tumors of Pancreatic, Gastrointestinal (GI), or Thoracic Origin or Poorly-differentiated Gastroenteropancreatic Neuroendocrine Carcinoma (GEP-NEC)Who this might be right forWell-differentiated Non-functional NET of Thoracic OriginWell-differentiated Non-functional NET of Gastrointestinal OriginWell-differentiated Non-functional NET of Pancreatic Origin+1 more Novartis Pharmaceuticals
Post-approval studies (Phase 4)UnknownNCT02759718What this trial is testingClinical Effectiveness of Serum Chromogranin A Levels on Diagnostic of Pancreatic Neuroendocrine TumorsWho this might be right forNon Functioning Pancreatic Endocrine Tumor Asan Medical Center 111
Large-scale testing (Phase 3)UnknownNCT02705651What this trial is testingNon-functioning Pancreatic Neuroendocrine Tumors in MEN1: Somatostatin Analogs Versus NO TreatmentWho this might be right forPancreatic Neuroendocrine Tumors in MEN1 Medical University of Vienna 180
Not applicableStudy completedNCT03918759What this trial is testingDiagnostic Accuracy of Preoperative Diagnostic Procedure in the Assessment of Lymph Node Metastases by NF-PanNENsWho this might be right forNon Functioning Pancreatic Endocrine Tumor IRCCS San Raffaele 100
Testing effectiveness (Phase 2)Study completedNCT02420691What this trial is testingRibociclib in Treating Patients With Advanced Neuroendocrine Tumors of Foregut OriginWho this might be right forAdvanced Digestive System Neuroendocrine NeoplasmDuodenal Neuroendocrine Tumor G1Functional Pancreatic Neuroendocrine Tumor+5 more M.D. Anderson Cancer Center 21
Large-scale testing (Phase 3)Study completedNCT00353496What this trial is testingStudy of Lanreotide Autogel in Non-functioning Entero-pancreatic Endocrine TumoursWho this might be right forEndocrine Tumors Ipsen 264
Not applicableUnknownNCT05566093What this trial is testingEUS-FNI for Nonfunctional Pancreatic Neuroendocrine TumorsWho this might be right forNonfunctional Pancreatic Neuroendocrine TumorPancreatic Neuroendocrine TumorEndoscopic Ultrasound Guangxi Medical University 20
Large-scale testing (Phase 3)Active Not RecruitingNCT03049189What this trial is testingEfficacy and Safety of 177Lu-edotreotide PRRT in GEP-NET PatientsWho this might be right forNeuroendocrine Tumors ITM Solucin GmbH 309